brusmith,
With Genta management anything is possible, but at this moment none of us know how this is going to play out, until it actually does.
Could they release "BAD NEWS on Friday" sure, but could they release "GOOD NEWS on Monday" sure.
(Take your pick.)
At this point in time, each and every investor must evaluate the circumstances of their investment, and make their decision wisely and to the best of their ability.
As I stated before one of two things are going to happen.
1.) Bad results will equal, quite a bit of, "I told you so". Posts in regards to how the company and management baited the common shareholders by way of PR's, so that noteholders could convert before the crash, will flood the boards.
2.) Good results will equal, quite a bit of, "relief by all parties involved here financially". The company will have finally turned the corner. Investors and the market itself, will finally find much needed faith in their R&D programs, and the PPS will reflect this fact immediately.
To be completely honest with you, I don't have a clue how this will turn out. My decision to hold my position is based on what I know of the trial, and my studies of Genasense over the past few years, so I patiently await the OS results from AGENDA.
I could be right, and the OS results could be very good, or I could be completely wrong and continuing the trial after missing the PFS endpoint was a lost cause which cost the common shareholders millions of dollars for no good reason.
(Of course I believe I am correct, otherwise I wouldn't be here. LOL.)
Best Regards, Bernie
AI
Market Data 
Markets 
